Table 4 Outcome at last follow-up in the... | American Society of Hematology

Table 4

Outcome at last follow-up in the 135 WAS patients who survived at least 2 years after transplantation

Group	N (%)
Status
Alive	130 (96.3)
Deceased†	5 (3.7)
*Active complications (observed in 39 patients)**
Chronic GVHD	20 (14.8)
Fatal sepsis‡	3 (2.2)
Autoimmune manifestations	12 (8.9)
Neurologic sequelae§	10 (7.4)

Group	N (%)
Status
Alive	130 (96.3)
Deceased†	5 (3.7)
*Active complications (observed in 39 patients)**
Chronic GVHD	20 (14.8)
Fatal sepsis‡	3 (2.2)
Autoimmune manifestations	12 (8.9)
Neurologic sequelae§	10 (7.4)

Defined as residual complications still active at the time of last follow-up.

One patient died in a car accident.

Two of them were splenectomized patients.

Composed of neurologic delay, epilepsy, spastic dysplasia, glaucoma, and various degrees of visual, hearing, and speech deficits.